Skip to content

Efficacy and Safety of Retroperitoneoscopic - assisted Lower Thoracic Paravertebral Block for Postoperative Analgesia in Nephrectomy

Efficacy and Safety of Retroperitoneoscopic - assisted Lower Thoracic Paravertebral Block for Postoperative Analgesia in Nephrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127298
Enrollment
Unknown
Registered
2026-06-29
Start date
2026-07-06
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal tumors, renal tuberculosis, and polycystic kidney disease.

Interventions

Retroperitoneoscopic - assisted Lower Thoracic Paravertebral Block:Retroperitoneoscopic - assisted Lower Thoracic Paravertebral Block
Retroperitoneoscopic - assisted Quadratus Lumborum Block:Retroperitoneoscopic - assisted Quadratus Lumborum Block

Sponsors

Ningbo Medical Centre Lihuili Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Sex: no restriction; 2. Age: 18-70 years; 3. BMI: 18-28 kg/m^2; 4. ASA: I-III.

Exclusion criteria

Exclusion criteria: 1. Patients with allergy to the study drug (e.g., ropivacaine); 2. Patients with infection, ulceration, or skin disease within 5 cm of the puncture site; 3. Patients with coagulation disorders or currently receiving anticoagulant therapy; 4. Patients on long-term analgesic therapy; 5. Patients with severe hepatic or renal insufficiency; 6. Patients with severe cardiovascular disease; 7. Patients with a clear history of neurological disease; 8. Patients with psychiatric disorders or cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Postoperative intravenous morphine equivalent within 48 hours;

Secondary

MeasureTime frame
Intraoperative indicators:Type of surgery;surgical site;operative time;tumor size;NRS scores at 2, 6, 12, 24, and 48 hours after surgery; QoR-15 score;

Countries

China

Contacts

Public ContactLingzhi Wang

Ningbo Medical Centre Lihuili Hospital

wlz19931231@163.com+86 152 6786 7801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026